Kreitzer Anatol 4
4 · MapLight Therapeutics, Inc. · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) Chief Discovery Officer Receives RSU Award
What Happened
Anatol Kreitzer, Chief Discovery Officer of MapLight Therapeutics (MPLT), was granted equity awards on February 5, 2026 totaling 30,475 units (6,020 shares and 24,455 derivative RSUs). The reported acquisition price for both entries is $0.00, meaning no cash was paid. The 24,455 units are reported as derivative RSUs (contingent rights to receive shares upon vesting).
Key Details
- Transaction date: 2026-02-05; Filing date: 2026-02-09 (filed four days after the grant; note this exceeds the typical 2-business-day Form 4 deadline).
- Grants reported: 6,020 shares @ $0.00 (direct award) and 24,455 RSUs @ $0.00 (derivative). Total awarded = 30,475 units.
- Shares owned after transaction: not specified in the provided excerpt of the filing.
- Footnotes from the filing:
- F1: The RSU award vests 1/4 on Jan 1, 2027, then 1/16 on each subsequent April 1, July 1, Oct 1 and Jan 1 thereafter, subject to continued service.
- F2: Each RSU represents a contingent right to receive one share of common stock upon vesting.
- F3: Describes an option vesting schedule (1/4 on Feb 5, 2027, then 1/48 monthly thereafter); included in the filing footnotes but separate from the RSU entries above.
- Transaction type code: A = Award/Grant.
Context
These are equity awards (RSUs and a direct share award), not open-market purchases or sales. RSUs are contingent — they convert into shares only as they vest per the schedule above — so this grant does not increase immediately tradeable shares. Grants to executives are common compensation and do not by themselves indicate intent to buy or sell stock.
Insider Transaction Report
- Award
Voting Common Stock
[F1][F2]2026-02-05+6,020→ 259,928 total - Award
Employee Stock Option (right to buy)
[F3]2026-02-05+24,455→ 24,455 totalExercise: $15.70Exp: 2036-02-04→ Voting Common Stock (24,455 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
- [F2]Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- [F3]1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.